LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug ...
Small particles of glass are to blame for the recall of a widely used fluticasone nasal spray that treats symptoms of hay fever in children. The nasal spray, known by its brand name Fluticasone ...
A nationwide recall has been issued by the makers of a nasal spray brand after glass particles were found inside of the spray. Apotex Corp, the company that makes Fluticasone Propionate Nasal Spray, ...
YARDLEY, Pa.--(BUSINESS WIRE)--Optinose, an ENT / Allergy specialty pharmaceutical company, announced today that the U.S. Food & Drug Administration (FDA) approved the Company’s New Drug Application ...
May 31 (UPI) --Pharmaceutical company Apotex Corp. announced a voluntary recall of its Fluticasone Propionate Nasal Spray on Thursday after it was found to contain glass particles. The Florida-based ...
Please provide your email address to receive an email when new articles are posted on . The Exhalation Delivery System reaches inflamed areas of the nasal cavity and sinuses that other sprays miss.
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, ...
November 13, 2009 (San Diego, California) — A combination of azelastine hydrochloride and fluticasone propionate nasal sprays administered in a single delivery device can significantly improve both ...
Please provide your email address to receive an email when new articles are posted on . An exhalation delivery system that uses fluticasone propionate nasal spray reduced the symptoms of chronic ...
Xhance (fluticasone propionate) is a prescription drug that’s used to treat chronic sinusitis. Xhance comes as a nasal spray. Xhance is used in adults to treat chronic (ongoing) sinusitis (sinus ...
Xhance was evaluated in five trials enrolling >1,500 adults. Optinose announced that the Food and Drug Administration (FDA) has approved Xhance (fluticasone propionate) Nasal Spray for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback